Lv6
1900 积分 2022-06-18 加入
RIG-I-targeted immunotherapy synergizes with immune checkpoint inhibition in a hepatocellular carcinoma model
22小时前
已完结
Discovery of small-molecule ATR inhibitors for potential cancer treatment: a patent review from 2014 to present
13天前
已完结
A medicinal chemistry perspective on ATR: Current status and future directions
13天前
已完结
The Trop-2-targeting antibody drug conjugate DB-1305 has higher antitumor activity and a potentially better safety profile compared with DS-1062
1个月前
已完结
DB-1303, a HER2-targeting ADC with a novel DNA topoisomerase I inhibitor, demonstrates a promising safety profile and anti-tumor efficacy with differentiation from DS-8201a
1个月前
已完结
Re-Evaluating Antibody–Drug Conjugate Linker Stability: Assessment, Interpretation, and Clinical Translation
2个月前
已完结
Loss of payload sensitivity and other mechanisms of resistance to T-DXd in HER2-mutant NSCLC: implications for subsequent responsiveness to HER2 TKIs
5个月前
已完结
Targeting the tumour cell surface in advanced prostate cancer
7个月前
已完结
Contactin-4 suppresses antitumor T cell responses by engaging amyloid precursor protein
8个月前
已完结
Fibroblast Activation Protein Alpha (FAPα) as a Promising Target in the Diagnostics and Treatment of Cancer and Fibrotic Diseases: Recent Approaches to Imaging and Assessment of Functional Activity
9个月前
已完结
皖公网安备34019202002308
